HR 242
115th Congress
House
Health
Health care costs and insurance
Inflation and prices
Medicare
Prescription drugs
Public contracts and procurement
Medicare Prescription Drug Price Negotiation Act of 2017
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 25, 2017
Referred to the Subcommittee on Health.
Jan 13, 2017
Referred to the Subcommittee on Health.
Jan 4, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 4, 2017
Introduced in House
Plain-English summary
Medicare Prescription Drug Price Negotiation Act of 2017
This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits CMS from doing so.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4